These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 710555)

  • 1. Experimental autoimmune myasthenia gravis: effects of calcium and potassium on the spontaneous release of neuromuscular transmitter.
    Kim YI; Sanders DB
    Exp Neurol; 1978 Sep; 61(2):311-7. PubMed ID: 710555
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic strategies in experimental autoimmune myasthenia gravis.
    Pestronk A; Drachman DB
    Ann N Y Acad Sci; 1981; 377():278-91. PubMed ID: 6978661
    [No Abstract]   [Full Text] [Related]  

  • 3. Degradation of acetylcholine receptor in diaphragms of rats with experimental autoimmune myasthenia gravis.
    Merlie JP; Heinemann S; Einarson B; Lindstrom JM
    J Biol Chem; 1979 Jul; 254(14):6328-32. PubMed ID: 447717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of myasthenia gravis as a disorder of acetylcholine receptors.
    Drachman DB; Pestronk A; Stanley EF
    Adv Cytopharmacol; 1979; 3():237-44. PubMed ID: 382787
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetylcholine receptors and myasthenia gravis.
    Drachman DB
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):26-30. PubMed ID: 504236
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
    Kelly JJ; Lambert EH; Lennon VA
    Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential susceptibility of young and old rat neuromuscular junctions to antibody-mediated AChR degradation in experimental autoimmune myasthenia gravis.
    Hoedemaekers A; Bessereau JL; Graus Y; Guyon T; Changeux JP; Berrih-Aknin S; Van Breda Vriesman P; De Baets M
    Ann N Y Acad Sci; 1998 May; 841():550-4. PubMed ID: 9668293
    [No Abstract]   [Full Text] [Related]  

  • 9. Diffusion of acetylcholine in the synaptic cleft of normal and myasthenia gravis human endplates.
    Cull-Candy SG; Miledi R; Uchitel OD
    Nature; 1980 Jul; 286(5772):500-2. PubMed ID: 7402330
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
    Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
    No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunology of acetylcholine receptors in relation to myasthenia gravis.
    Vincent A
    Physiol Rev; 1980 Jul; 60(3):756-824. PubMed ID: 6248907
    [No Abstract]   [Full Text] [Related]  

  • 12. The kinetics of transmitter release in myasthenia gravis. I. An electrophysiological analysis of the storage of transmitter.
    Bergmans J; Rosselle N; Verheyen G; Schellens L
    Electromyogr Clin Neurophysiol; 1972; 12(5):443-88. PubMed ID: 4350884
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome.
    Lindstrom J
    Annu Rev Immunol; 1985; 3():109-31. PubMed ID: 2998417
    [No Abstract]   [Full Text] [Related]  

  • 15. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome.
    Lindstrom JM; Lambert EH
    Neurology; 1978 Feb; 28(2):130-8. PubMed ID: 202890
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of epinephrine, ouabain, and insulin in experimental autoimmune myasthenia gravis.
    Takamori M; Mori M; Ide Y; Kasai M
    Neurology; 1980 Feb; 30(2):167-71. PubMed ID: 6243761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.
    Almon RR; Andrew CG; Appel SH
    Science; 1974 Oct; 186(4158):55-7. PubMed ID: 4421998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of myasthenia gravis.
    Heilbronn E; Stålberg E
    J Neurochem; 1978 Jul; 31(1):5-11. PubMed ID: 209148
    [No Abstract]   [Full Text] [Related]  

  • 19. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
    Takamori M; Sakato S; Okumura S
    J Neurol Sci; 1984; 66(2-3):245-53. PubMed ID: 6099402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis.
    Kao I; Drachman DB
    Science; 1977 Jan; 195(4273):74-5. PubMed ID: 831257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.